Ann: Dronabinol Supply Agreement/Sleep Apnoea Trial Update, page-64

First parcel September 2018 during the little volume fiasco that got it on the radar for me.
Bought a lot more early June 2019.

No sell order either for me, you'd be crazy to bar the first trial results not even coming through yet.
I would only consider placing a sell order if I think the market overreacts to a catalyst i.e the $BIT f*ing crazy pump last year.

I am using our peers, good ones are BOT.ax and AGH.ax as a way to gauge IHL's value compared to theirs, as well as overall market sentiment.
$BOT roughly at 200M MC as of now, $IHL only at 27M MC.

$BOT with one successful phase 1 trial, more in the pipeline and ongoing. Also losing gorillions of cash per quarter, making none.
$IHL with no successful trials to date. 4 in the pipeline funded by CannVaLate to come 2H 2019 and 2020. Losing roughly 300k per quarter, improving every quarter.

Risk v Reward fairly obvious here, even at my most conservative estimates of trial success and perceived market valuation this still has a long way to go from the current SP. DYOR